Literature DB >> 28157546

Respiratory syncytial virus infection induces a subset of types I and III interferons in human dendritic cells.

Philippa Hillyer1, Viraj P Mane1, Aaron Chen1, Maria B Dos Santos1, Lynnsie M Schramm1, Rachel E Shepard1, Cindy Luongo2, Cyril Le Nouën2, Lei Huang3, Lihan Yan3, Ursula J Buchholz2, Ronald G Jubin4, Peter L Collins2, Ronald L Rabin5.   

Abstract

Whether respiratory syncytial virus (RSV) induces severe infantile pulmonary disease may depend on viral strain and expression of types I and III interferons (IFNs). These IFNs impact disease severity by inducing expression of many anti-viral IFN-stimulated genes (ISGs). To investigate the impact of RSV strain on IFN and ISG expression, we stimulated human monocyte-derived DCs (MDDCs) with either RSV A2 or Line 19 and measured expression of types I and III IFNs and ISGs. At 24h, A2 elicited higher ISG expression than Line 19. Both strains induced MDDCs to express genes for IFN-β, IFN-α1, IFN-α8, and IFN-λ1-3, but only A2 induced IFN-α2, -α14 and -α21. We then show that IFN-α8 and IFN-α14 most potently induced MDDCs and bronchial epithelial cells (BECs) to express ISGs. Our findings demonstrate that RSV strain may impact patterns of types I and III IFN expression and the magnitude of the ISG response by DCs and BECs. Published by Elsevier Inc.

Entities:  

Keywords:  Bronchial epithelial cell; Dendritic cell; Innate immunity; Interferon; Interferon stimulated gene; Interferon subtype; Respiratory syncytial virus

Mesh:

Substances:

Year:  2017        PMID: 28157546      PMCID: PMC5337151          DOI: 10.1016/j.virol.2017.01.017

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  45 in total

1.  IL-4 and IL-13 induce SOCS-1 gene expression in A549 cells by three functional STAT6-binding motifs located upstream of the transcription initiation site.

Authors:  Daniel Hebenstreit; Petra Luft; Angela Schmiedlechner; Gerhard Regl; Anna-Maria Frischauf; Fritz Aberger; Albert Duschl; Jutta Horejs-Hoeck
Journal:  J Immunol       Date:  2003-12-01       Impact factor: 5.422

2.  Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). I. Isolation, properties and characterization.

Authors:  R CHANOCK; B ROIZMAN; R MYERS
Journal:  Am J Hyg       Date:  1957-11

3.  The role of IFN in respiratory syncytial virus pathogenesis.

Authors:  Joan E Durbin; Teresa R Johnson; Russell K Durbin; Sara E Mertz; Rafaella A Morotti; R Stokes Peebles; Barney S Graham
Journal:  J Immunol       Date:  2002-03-15       Impact factor: 5.422

4.  The histopathology of fatal untreated human respiratory syncytial virus infection.

Authors:  Joyce E Johnson; Ricardo A Gonzales; Sandy J Olson; Peter F Wright; Barney S Graham
Journal:  Mod Pathol       Date:  2006-11-24       Impact factor: 7.842

5.  Differential response of dendritic cells to human metapneumovirus and respiratory syncytial virus.

Authors:  Antonieta Guerrero-Plata; Antonella Casola; Giovanni Suarez; Xiang Yu; LeAnne Spetch; Mark E Peeples; Roberto P Garofalo
Journal:  Am J Respir Cell Mol Biol       Date:  2005-11-11       Impact factor: 6.914

6.  Respiratory syncytial virus decreases the capacity of myeloid dendritic cells to induce interferon-gamma in naïve T cells.

Authors:  H Bartz; O Türkel; S Hoffjan; T Rothoeft; A Gonschorek; U Schauer
Journal:  Immunology       Date:  2003-05       Impact factor: 7.397

7.  SOCS-1 and SOCS-3 inhibit IL-4 and IL-13 induced activation of Eotaxin-3/CCL26 gene expression in HEK293 cells.

Authors:  Daniel Hebenstreit; Petra Luft; Angela Schmiedlechner; Albert Duschl; Jutta Horejs-Hoeck
Journal:  Mol Immunol       Date:  2005-02       Impact factor: 4.407

8.  Immunological properties of plaque purified strains of live attenuated respiratory syncytial virus (RSV) for human vaccine.

Authors:  M L Herlocher; M Ewasyshyn; S Sambhara; M Gharaee-Kermani; D Cho; J Lai; M Klein; H F Maassab
Journal:  Vaccine       Date:  1999-01       Impact factor: 3.641

Review 9.  Respiratory syncytial virus mechanisms to interfere with type 1 interferons.

Authors:  Sailen Barik
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

10.  Dynamic expression profiling of type I and type III interferon-stimulated hepatocytes reveals a stable hierarchy of gene expression.

Authors:  Christopher R Bolen; Siyuan Ding; Michael D Robek; Steven H Kleinstein
Journal:  Hepatology       Date:  2014-02-18       Impact factor: 17.425

View more
  16 in total

1.  CD38 modulates respiratory syncytial virus-driven proinflammatory processes in human monocyte-derived dendritic cells.

Authors:  Ilaria Schiavoni; Carolina Scagnolari; Alberto L Horenstein; Pasqualina Leone; Alessandra Pierangeli; Fabio Malavasi; Clara M Ausiello; Giorgio Fedele
Journal:  Immunology       Date:  2017-12-18       Impact factor: 7.397

2.  Differential interferon gene expression in bronchiolitis caused by respiratory syncytial virus-A genotype ON1.

Authors:  Alessandra Pierangeli; Agnese Viscido; Camilla Bitossi; Federica Frasca; Massimo Gentile; Giuseppe Oliveto; Antonella Frassanito; Raffaella Nenna; Fabio Midulla; Carolina Scagnolari
Journal:  Med Microbiol Immunol       Date:  2019-09-04       Impact factor: 3.402

3.  Differential Responses by Human Respiratory Epithelial Cell Lines to Respiratory Syncytial Virus Reflect Distinct Patterns of Infection Control.

Authors:  Philippa Hillyer; Rachel Shepard; Megan Uehling; Mina Krenz; Faruk Sheikh; Kalyn R Thayer; Lei Huang; Lihan Yan; Debasis Panda; Cindy Luongo; Ursula J Buchholz; Peter L Collins; Raymond P Donnelly; Ronald L Rabin
Journal:  J Virol       Date:  2018-07-17       Impact factor: 5.103

4.  GBP5 Is an Interferon-Induced Inhibitor of Respiratory Syncytial Virus.

Authors:  Zhaolong Li; Xinglong Qu; Xin Liu; Chen Huan; Hong Wang; Zhilei Zhao; Xu Yang; Shucheng Hua; Wenyan Zhang
Journal:  J Virol       Date:  2020-10-14       Impact factor: 5.103

5.  Control of IFN-I responses by the aminopeptidase IRAP in neonatal C57BL/6 alveolar macrophages during RSV infection.

Authors:  Carole Drajac; Daphné Laubreton; Quentin Marquant; Claire Chottin; Cécile Ferret; Edwige Bouguyon; Isabelle Schwartz-Cornil; Loredana Saveanu; Sabine Riffault; Delphyne Descamps
Journal:  Mucosal Immunol       Date:  2021-04-12       Impact factor: 7.313

6.  Transient Depletion of CD169+ Cells Contributes to Impaired Early Protection and Effector CD8+ T Cell Recruitment against Mucosal Respiratory Syncytial Virus Infection.

Authors:  Dong Sun Oh; Ji Eun Oh; Hi Eun Jung; Heung Kyu Lee
Journal:  Front Immunol       Date:  2017-07-13       Impact factor: 7.561

Review 7.  Decoding type I and III interferon signalling during viral infection.

Authors:  Emily V Mesev; Robert A LeDesma; Alexander Ploss
Journal:  Nat Microbiol       Date:  2019-04-01       Impact factor: 17.745

Review 8.  Early-Life Respiratory Syncytial Virus Infection, Trained Immunity and Subsequent Pulmonary Diseases.

Authors:  Carrie-Anne Malinczak; Nicholas W Lukacs; Wendy Fonseca
Journal:  Viruses       Date:  2020-05-04       Impact factor: 5.048

Review 9.  Innate Immune Components that Regulate the Pathogenesis and Resolution of hRSV and hMPV Infections.

Authors:  Catalina A Andrade; Gaspar A Pacheco; Nicolas M S Gálvez; Jorge A Soto; Susan M Bueno; Alexis M Kalergis
Journal:  Viruses       Date:  2020-06-12       Impact factor: 5.048

10.  Respiratory syncytial virus activates epidermal growth factor receptor to suppress interferon regulatory factor 1-dependent interferon-lambda and antiviral defense in airway epithelium.

Authors:  A Kalinowski; B T Galen; I F Ueki; Y Sun; A Mulenos; A Osafo-Addo; B Clark; J Joerns; W Liu; J A Nadel; C S Dela Cruz; J L Koff
Journal:  Mucosal Immunol       Date:  2018-02-07       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.